Our Team

PSFC Staff

team 5

Nora Benavidez

Nora Benavidez, PhD serves as the Director of Operations. She supports the PSFC team in managing strategic operational projects, providing communication resources, and maintaining strong relationships with our member and donor community.

Prior to joining the team, Nora received research training from MIT, Columbia, UCSF, UCLA, and at USC where she completed her doctorate in Neuroscience. Her research has been published in peer-reviewed journals including Nature and Neuron, and she was awarded two NIH grants to reveal brain-wide connectivity maps underlying multisensory integration and neuropsychiatric disorders.

Sarah Harpold

Sarah serves as the Community Engagement Manager for PSFC, leveraging over 10 years of experience in operations, communications, and event production. Sarah produces the behind-the-scenes efforts that unite our community, such as events, webinars, affinity groups, and newsletters, while also managing our rapidly expanding member base.

Sarah has a dynamic professional background ranging from producing corporate events for The Boeing Company, to managing event operations and communications for Burning Man Project. Her passion for organizational development and creative production stems from her upbringing in Alaska, where she was raised on the values of community, resiliency, and creative problem-solving.

team 6

Whitney Black

Whitney Black is a collaborative thought partner across a diverse and complex range of PSFC projects and initiatives. Whitney brings over two decades of experience supporting mission driven Founders and Entrepreneurs in politics, life sciences, venture capital and philanthropy.

She served as Chief of Staff to California State Lobbyist Darius Anderson, working on statewide policy and legislative affairs, and spent close to a decade in the Family Office of entrepreneur and philanthropist Sean Parker. She helped establish The Parker Foundation and worked alongside the Parker Institute for Cancer Immunotherapy. Most recently, she worked as Executive Assistant and strategic partner to a fellow PSFC member, author, and philanthropist, Tim Ferriss.

In her free time she loves climbing rocks, running trails, and spending connected time with her community.

Alexandre Lehmann

Putting the “S” in PSFC, Alexandre Lehmann (Dr. Alex) contributes to strategy, due diligence, and liaises with clinical, academic, and regulatory stakeholders. Trained as an executive engineer (M.Eng) and cognitive neuroscientist (Ph.D.), he is fascinated by the intersection of brain plasticity, music, and non-ordinary states.

Supporting MAPS since 2002, Dr. Alex co-founded a nonprofit in 2007, curating one of the earliest psychedelic science conference series. He established himself as a trusted psychedelic science adviser to media and nonprofits. His contributions include consulting on the translation and penning a guest commentary for the 2010 article “Hallucinogens as Medicine” by Grob & Griffiths in the French edition of Scientific American.

Dr. Alex also brings over 15 years of experience in neuroscience and health research. At McGill University, he has been leading a healthcare research program focused on brain plasticity. He has volunteered for peer-support initiatives and curated keynotes at cultural events.

team 7

Graham Boyd

Graham Boyd is an attorney specializing in efforts to reform drug laws, reduce mass incarceration, and support science-based access to healing. Graham is the co-founder and executive director of the Psychedelic Science Funders Collaborative (PSFC).

Graham is also the founding director of New Approach Advocacy Fund, through which he has led the opinion research, legal drafting and campaign design for policy reform measures throughout the United States. He has led 21 statewide ballot initiative campaigns, including legalization of cannabis, creation of access to psilocybin therapy and broader criminal justice reform.

Previously, Graham was the founding director of the national ACLU’s Drug Law Reform Project, a national litigation project addressing civil rights and civil liberties consequences of punitive drug policies. Graham graduated summa cum laude from Yale University in 1987 and received his J.D. from Yale Law School in 1992.

Mary Lim

Mary Lim is a seasoned management professional with a dynamic blend of academic excellence and cross-industry experience. A graduate of the University of the Philippines Diliman, she holds a bachelor’s degree in Hotel, Restaurant, and Institution Management, complemented by a solid foundation in Geodetic Engineering.

Prior to her current roles, Mary led the Systems and Innovation Department for a leading restaurant group in the Philippines, where she supported cross-functional teams and over one hundred store locations. In this capacity, she drove operational efficiency and organizational growth through strategic systems implementation and process improvements. She also previously worked as Project Support at the Center for Humane Technologies and served as an Executive Assistant at MOTIV Partners, further broadening her experience across mission-driven organizations and executive operations.

Mary currently serves as PSFC’s Executive Assistant and Project Manager, where she oversees a broad range of responsibilities and contributes to key operational initiatives. She also plays an important role as a staff member at the Psychedelic Mental Health Access Alliance (PMHA Alliance).

Beyond her professional work, Mary is deeply committed to service and community engagement. She formerly served as Chairperson of the Youth Volunteer Workers’ Group at the YMCA of Quezon City and is currently an active volunteer at Tokyo YMCA, reflecting her ongoing dedication to leadership and meaningful community contribution.

Mary currently serves as Executive Assistant to Graham Boyd at the Psychedelic Science Funders Collaborative, handling diverse management tasks and contributing to operational projects. Simultaneously, she holds the position of Executive Assistant at New Approach PAC and makes a significant impact as a Project Manager at the Psychedelic Health Equity Initiative.

Mary formerly served as the Chairperson of the Youth Volunteer Workers’ Group at the YMCA of Quezon City and is currently an active volunteer at Tokyo YMCA in Japan.

Ben Collins

Ben Collins is Director of Programs and Partnerships at Psychedelic Science Funders Collaborative, where he is involved with PSFC’s philanthropic strategy, partnerships, and grantmaking. He has a background in impact investment, climate and human rights policy, and nonprofit management.

Prior to PSFC, he served as Associate Director of MSI Integrity, a human rights research and advocacy organization focused on sustainability and labor rights standards. Previously, he was a senior researcher for Rainforest Action Network’s climate and energy program, where his publications received coverage in the Financial Times and Bloomberg.

He graduated from Harvard College and received a Master in Public Policy degree from the Harvard Kennedy School, where he was a Belfer International and Global Affairs fellow and a Public Service fellow.

Rose Uzunova

As Chief Community Officer at PSFC, Rose helps foster a community of informed, connected and unified philanthropists, who co-create the critical mass required to affect systemic change.

PSFC Board of Directors

Joe Green

Joe supports causes that have a high potential for systemic impact, yet limited resources to achieve their full potential. PSFC was created because medical trials of MDMA and psilocybin have shown compelling evidence to treat millions of people who suffer from mental health issues, but there was insufficient funding to complete the next phase of trials.

Joe is a social entrepreneur who has spent his career addressing significant challenges by marrying technology with community organizing. Joe co-founded Causes, which empowered more than 100 million people to make an impact; NationBuilder, a leading software provider for organizers; and FWD.us, which has mobilized the tech community around immigration and criminal justice reform.

He is currently the chairman and co-founder of Treehouse, an organization that builds communal housing apartment buildings in Los Angeles, and chairman of Or Halev, a center for Jewish meditation.

Graham Boyd

Graham has spent his career fighting on behalf of social justice causes. Through his work advocating for those who have been marginalized, Graham was introduced to psychedelic science.

Recognizing that those who will benefit from physician-prescribed MDMA and psilocybin are often suffering in silence, he brings his expertise from past efforts to help raise funds and resources to further the FDA process and bring needed relief to veterans, abuse survivors and others who are struggling with PTSD, depression and anxiety.

Genevieve Jurvetson

Genevieve leads giving for The Jurvetson Family Foundation. Before diving into the world of philanthropy, Genevieve was co-founder and CMO of Fetcher, an AI-powered recruiting startup. Prior to Fetcher, Genevieve ran marketing for Apartment List, the fastest-growing online rental marketplace in the U.S. She spent the first 8 years of her career in investment banking and investment management, most recently at Goldman Sachs.

Genevieve earned a B.S. with Highest Honors from Georgia Tech and an MBA from MIT. Genevieve and her husband Steve live in the Bay Area with their five children.

Suprotik (Protik) Basu

Protik’s life and career has spanned the worlds of private finance, philanthropy, public policy, and global public health. Protik is Managing Partner of Helena Special Investments, a problem-solving institution that addresses urgent societal issues through for-profit, non-profit, and legislative action. Helena’s investment arm backs companies addressing critical global problems like plastics pollution, chronic disease, climate change, and mental health.

Most recently, Protik co-founded a structured credit fund that invested in entrepreneurs across Latin and Central America, focusing on agribusiness, healthcare, and technology. During his work in global public health, Protik lead a decade-long effort to mobilize and deploy over $3.5B in public and private capital to end deaths from malaria in sub-Saharan Africa, and to improve child and maternal health in sub-Saharan Africa and South Asia. Through the distribution of over 2 billion mosquito nets and hundreds of millions of medications, this public-private partnership saved the lives of over 7 million children from malaria in one of the largest public health efforts in history.

David Bronner

As the CEO of Dr. Bronner’s, the top-selling brand of natural soap in North America, David has looked for innovative solutions to problems his entire professional life.

Continuing with this outlook, and looking to create positive change in the world, David has been a long time supporter of psychedelic science and funder of the FDA process for MDMA and psilocybin to treat PTSD, depression and other forms of mental illness.

Dan Grossman

Previously, Dan served as Managing Director and Senior Partner at Boston Consulting Group (BCG), one of the world’s preeminent management consulting firms. He had over 20 years of experience in BCG’s health care practice area, working with leading biopharmaceutical and medical technology companies on issues of corporate strategy, pipeline development and commercializing innovation globally. His experience spans therapeutic areas, with significant depth across major areas of neuroscience.

Dan served as the head of learning & development for BCG in North America; and presently serves as a board member and chair of the impact advisory committee for Lykos Therapeutics; as treasurer and executive committee member of the board of trustees of the Lyric Opera of Chicago; and as a founding board member of the Math Cultural Center of Chicago. He holds a Ph.D. in mathematics from Princeton University and a B.A. from Harvard College, and taught math at the University of Chicago prior to joining BCG.

Michael Cotton

Michael Cotton is a veteran-managed care executive with over 20 years’ experience leading high quality innovative organizations.

Over the course of Michael’s tenure as Chief Operating Officer and other senior executive roles at Meridian Health, a multi-state managed care provider, he focused on continuous improvement, efficiency, and population health strategies that emphasized better patient outcomes. This was instrumental in Meridian’s plans consistently achieving the highest quality ratings in the country while servicing in excess of a million Medicaid-eligible citizens.

Reaching beyond Medicaid, Michael was instrumental in bringing Meridian’s award-winning managed care services to tens of thousands of Medicare participants. He currently leverages this keen operational acumen and decades of experience to a number of entrepreneurial endeavors and as a trusted advisor to Enthea.